AQSTAquestive Therapeutics, Inc.

AQST Stock Price, Valuation & Chart | Aquestive Therapeutics, Inc.

$5.240+0.13 (+2.54%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic AQST intrinsic value AQST calculated fair value vs price

Overview Financials Dividends Ratios

AQST Historical price chart

AQST Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization657.45M

PE Ratio-8.06

EPS-0.65

Trading Volume2.16M

Today's High/Low5.34/5.08

Dividend Yield0.00

52 Week High/Low7.55/2.93

Shares Outstanding125.47M

AQST Financial Statement

AQST Analyst ratings

AQST Analysis & performance metrics

AQST Company profile

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United…

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and…

AQST Management team

Name

Position

Lori J. Braender BSBA, Esq., J.D.

Chief Legal Officer, Chief Compliance Officer & Secretary

Sherry Korczynski

Senior Vice President of Sales & Marketing

Daniel BarberCEO

Chief Executive Officer, President & Director

A. Ernest Toth Jr.CFO

Chief Financial Officer

Cassie JungCOO

Chief Operating Officer

Carl N. Kraus M.D.

Chief Medical Officer

Melina T. Cioffi

Senior Vice President of Regulatory Affairs

Peter E. Boyd

Senior Vice President of Information Technology & Human Resources

Name

Position

Lori J. Braender BSBA, Esq., J.D.

Chief Legal Officer, Chief Compliance Officer & Secretary

Sherry Korczynski

Senior Vice President of Sales & Marketing

Daniel BarberCEO

Chief Executive Officer, President & Director

A. Ernest Toth Jr.CFO

Chief Financial Officer

Cassie JungCOO

Chief Operating Officer

Carl N. Kraus M.D.

Chief Medical Officer

Melina T. Cioffi

Senior Vice President of Regulatory Affairs

Peter E. Boyd

Senior Vice President of Information Technology & Human Resources

Management Team

Lori J. Braender BSBA, Esq., J.D.

Chief Legal Officer, Chief Compliance Officer & Secretary

Sherry Korczynski

Senior Vice President of Sales & Marketing

Daniel BarberCEO

Chief Executive Officer, President & Director

A. Ernest Toth Jr.CFO

Chief Financial Officer

Cassie JungCOO

Chief Operating Officer

Carl N. Kraus M.D.

Chief Medical Officer

Melina T. Cioffi

Senior Vice President of Regulatory Affairs

Peter E. Boyd

Senior Vice President of Information Technology & Human Resources

Management

Lori J. Braender BSBA, Esq., J.D.

Chief Legal Officer, Chief Compliance Officer & Secretary

Sherry Korczynski

Senior Vice President of Sales & Marketing

Daniel BarberCEO

Chief Executive Officer, President & Director

A. Ernest Toth Jr.CFO

Chief Financial Officer

Cassie JungCOO

Chief Operating Officer

Carl N. Kraus M.D.

Chief Medical Officer

Melina T. Cioffi

Senior Vice President of Regulatory Affairs

Peter E. Boyd

Senior Vice President of Information Technology & Human Resources

Total 8 executives

AQST Frequently asked questions

What is Aquestive Therapeutics, Inc. (AQST) Stock Price?

Current stock price of Aquestive Therapeutics, Inc. (AQST) stock is $5.240. The stock price is +2.54% higher in the session. The intraday range can be seen from this page. Volume of Aquestive Therapeutics, Inc. (AQST) stock is 2.16M.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Aquestive Therapeutics, Inc. (AQST) stock price going up or down today?

The stock price of Aquestive Therapeutics, Inc. (AQST) can change with earnings, company news, and overall market sentiment. Aquestive Therapeutics, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Aquestive Therapeutics, Inc. stock expensive at its current price?

Whether Aquestive Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AQST on this page is -8.06. EPS on this page is -0.65. Compare those figures with peers and growth expectations before deciding if the current Aquestive Therapeutics, Inc. price is justified.

How has the stock price of Aquestive Therapeutics, Inc. (AQST) performed historically?

Historical performance for Aquestive Therapeutics, Inc. (AQST) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AQST reacted to past earnings and market events.

Should I buy Aquestive Therapeutics, Inc. (AQST) stock, at this price?

Buying Aquestive Therapeutics, Inc. (AQST) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.